Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
Clinical trial NCT05509400 · COMPLETED
Trial details
- NCT number
- NCT05509400
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2025-03-10
- Enrollment
- 813
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.